Compare Globalstar (GSAT) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globalstar vs Novavax Inc — how do they compare? Globalstar trades at $83.82 (market cap $10.78B), while Novavax Inc trades at $12.75 (market cap $1.82B). The key difference: Globalstar is far larger — about 5.9× Novavax Inc's market cap, and Globalstar is more actively traded (723,953 versus 6,198,505). Which is the better fit depends on your goals — on Pluang, investors hold Globalstar for 21 Days and Novavax Inc for 59 Days on average.
| GSAT | NVAX | |
|---|---|---|
Market Cap | $10.78B | $1.82B |
Volume | 723,953 | 6,198,505 |
Sector | Media | Health |
52-Week High | $84.43 | $12.56 |
52-Week Low | $41.54 | $6.22 |
Typical Hold Time | 21 Days | 59 Days |
Enterprise Value | $10.79B | $1.39B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and strong analyst support (73.9% buy ratings). The company reported revenue of $1.12B in 2025 with a net income of $440.3M, marking a significant turnaround from prior losses, though 2026 projections show a return to negative net income. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.
The outlook is mixed: strong valuation ratios (P/E of 3.14, EV/EBITDA of 1.72) and recent earnings beats suggest undervaluation, but persistent cash burn and negative equity pose risks. Investment opportunity lies in partnership-driven growth, while risks include execution challenges and reliance on vaccine demand. Wall Street sentiment remains optimistic despite fundamental volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globalstar
Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.
Read more on GSAT →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
